Fengtao Su

560 total citations
20 papers, 447 citations indexed

About

Fengtao Su is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fengtao Su has authored 20 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Fengtao Su's work include DNA Repair Mechanisms (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Fengtao Su is often cited by papers focused on DNA Repair Mechanisms (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Fengtao Su collaborates with scholars based in China, United States and France. Fengtao Su's co-authors include Aroumougame Asaithamby, Shibani Mukherjee, Souparno Bhattacharya, Ritu Mishra, Salim Abdisalaam, Srinivasan Kalayarasan, Subroto Ghose, Guangming Zhou, Igor Dozmorov and Edward K. Wakeland and has published in prestigious journals such as Nucleic Acids Research, Frontiers in Microbiology and Molecular Cancer.

In The Last Decade

Fengtao Su

20 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengtao Su China 10 307 148 138 68 49 20 447
Yanning Gao China 12 215 0.7× 146 1.0× 83 0.6× 38 0.6× 53 1.1× 37 389
Alex Frías Spain 6 273 0.9× 176 1.2× 96 0.7× 33 0.5× 41 0.8× 8 387
Veronica E. Manzo United States 5 205 0.7× 85 0.6× 125 0.9× 31 0.5× 68 1.4× 7 359
Bingshu Xia China 9 204 0.7× 116 0.8× 95 0.7× 60 0.9× 45 0.9× 13 347
Piera Aiello Italy 11 185 0.6× 161 1.1× 94 0.7× 100 1.5× 36 0.7× 17 390
Ruqian Lyu Australia 6 211 0.7× 125 0.8× 110 0.8× 68 1.0× 52 1.1× 7 348
Asona Lui United States 10 157 0.5× 110 0.7× 80 0.6× 81 1.2× 94 1.9× 21 333
Liting You China 9 182 0.6× 152 1.0× 65 0.5× 73 1.1× 63 1.3× 25 412
Amirtharaj Francis India 12 179 0.6× 110 0.7× 141 1.0× 82 1.2× 46 0.9× 20 379
Jay Pilrose United States 8 422 1.4× 128 0.9× 229 1.7× 47 0.7× 26 0.5× 12 567

Countries citing papers authored by Fengtao Su

Since Specialization
Citations

This map shows the geographic impact of Fengtao Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengtao Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengtao Su more than expected).

Fields of papers citing papers by Fengtao Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengtao Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengtao Su. The network helps show where Fengtao Su may publish in the future.

Co-authorship network of co-authors of Fengtao Su

This figure shows the co-authorship network connecting the top 25 collaborators of Fengtao Su. A scholar is included among the top collaborators of Fengtao Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengtao Su. Fengtao Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Qingting, Li Chen, Shikai Geng, et al.. (2025). Inhibition of DDR1 potentiates carbon ion radiotherapy by promoting ferroptosis and immunogenic death in head and neck squamous cell carcinoma. Journal of Translational Medicine. 23(1). 1011–1011. 1 indexed citations
2.
Chen, Li, Wanzun Lin, Fangzhu Wan, et al.. (2025). Carbon ion combined photon radiotherapy induces ferroptosis via NCOA4-mediated ferritinophagy in glioblastoma. Redox Biology. 86. 103865–103865. 1 indexed citations
3.
Ye, Wei, Tingting Xu, Xin Zhou, et al.. (2023). CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus–Driven Oropharyngeal Cancer. Cancer Immunology Research. 11(3). 306–319. 12 indexed citations
4.
Xu, Bing, Xiaofei Zhang, Hui Chen, et al.. (2023). Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapy. Journal of Thoracic Disease. 15(4). 1805–1822. 3 indexed citations
5.
6.
Li, Fangfang, Dashan Ai, Yun Chen, et al.. (2023). Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials. The Oncologist. 28(8). e645–e652. 5 indexed citations
7.
Zhang, Xiaofei, Peiyi Liu, Di Liu, et al.. (2022). Treatment outcomes of 156 patients with cervical esophageal cancers treated with definitive radiation therapy- A single-institution experience of a rare cancer. Frontiers in Oncology. 12. 929583–929583. 2 indexed citations
8.
Wen, Junmiao, Wei Ye, Salma K. Jabbour, et al.. (2021). Comprehensive analysis of prognostic value of lymph node staging classifications in patients with head and neck squamous cell carcinoma after cervical lymph node dissection. European Journal of Surgical Oncology. 47(7). 1710–1717. 7 indexed citations
9.
Ye, Wei, Chong Li, Weijun Qian, et al.. (2021). Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome. Molecular Cancer. 20(1). 5–5. 18 indexed citations
10.
Xu, Tingting, Chunying Shen, Wei Ye, et al.. (2020). Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil. Cancer Medicine. 9(18). 6556–6564. 17 indexed citations
11.
Li, Chong, Lungen Lu, Zhongtian Qi, et al.. (2020). Transcriptome and miRNome Analysis Provide New Insight Into Host Lipid Accumulation, Innate Immunity, and Viral Persistence in Hepatitis C Virus Infection in vitro. Frontiers in Microbiology. 11. 535673–535673. 6 indexed citations
12.
Wang, Jin, Huan Chen, Shouli Wang, et al.. (2018). MicroRNA‑200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c‑Met signaling pathway. Oncology Reports. 41(3). 1497–1508. 26 indexed citations
13.
Bhattacharya, Souparno, Srinivasan Kalayarasan, Salim Abdisalaam, et al.. (2017). RAD51 interconnects between DNA replication, DNA repair and immunity. Nucleic Acids Research. 45(8). 4590–4605. 132 indexed citations
14.
Su, Fengtao, Souparno Bhattacharya, Salim Abdisalaam, et al.. (2015). Replication stress induced site-specific phosphorylation targets WRN to the ubiquitin-proteasome pathway. Oncotarget. 7(1). 46–65. 25 indexed citations
15.
Su, Fengtao, et al.. (2015). FANCD2 influences replication fork processes and genome stability in response to clustered DSBs. Cell Cycle. 14(12). 1809–1822. 20 indexed citations
16.
Su, Fengtao, Shibani Mukherjee, Yanyong Yang, et al.. (2014). Nonenzymatic Role for WRN in Preserving Nascent DNA Strands after Replication Stress. Cell Reports. 9(4). 1387–1401. 63 indexed citations
17.
He, Jinpeng, Fengtao Su, Nan Ding, et al.. (2013). Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition. Cell Death and Disease. 4(6). e699–e699. 81 indexed citations
18.
Wang, Jufang, Fengtao Su, Lubomir B. Smilenov, et al.. (2011). Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity. Radiation Oncology. 6(1). 96–96. 5 indexed citations
19.
Su, Fengtao, Lubomir B. Smilenov, Thomas Ludwig, et al.. (2010). Hemizygosity for Atm and Brca1 influence the balance between cell transformation and apoptosis. Radiation Oncology. 5(1). 15–15. 14 indexed citations
20.
Ouyang, Tao, et al.. (2008). China multicenter study of sentinel node biopsy substituting axillary node dissection: CBCSG-01 trial. European Journal of Cancer Supplements. 6(7). 170–171. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanning Gao Breakdown of academic impact, for papers by Alex Frías Breakdown of academic impact, for papers by Veronica E. Manzo Breakdown of academic impact, for papers by Bingshu Xia Breakdown of academic impact, for papers by Piera Aiello Breakdown of academic impact, for papers by Ruqian Lyu Breakdown of academic impact, for papers by Asona Lui Breakdown of academic impact, for papers by Liting You Breakdown of academic impact, for papers by Amirtharaj Francis Breakdown of academic impact, for papers by Jay Pilrose
Rankless by CCL
2026